• Tingting Li

    Associate professor
    Research:Pharmacology
    Tel:
    E-mail:lttcpu@cpu.edu.cn
    Office:Research building, Room 420
    Laboratory:
  • Molecular Mechanism and Drug Research of Liver Diseases

    Transcriptional regulation of drug metabolizing enzy


    Molecular Mechanism and Drug Research of Liver Diseases

    Transcriptional regulation of drug metabolizing enzy


    Research Projects

    1. National Natural Science Foundation of China (youth project), 81503150, 2016/01-2018/12.

    2. Natural Science Foundation of Jiangsu Province (youth project), BK20130657, 2013/07-2016/06.

    3. Fundamental Research Funds for the Central Universities (key project), 2632019ZD05, 2019/01-2020/12.

    4. Stater Key Laboratory of Natural Medicines, ZJ11176, 2011/12-2013/12.

     


    1. Wang, Y.Z.; Wang Y.L.; Che H.J.; Jia Y.H.; Wang H.F.; Zuo L.F.; Yang K.; Li T.T.*Wang J.X.* Sappanone A: A natural PDE4 inhibitor with dual anti-inflammatory and antioxidant activities from the heartwood of Caesalpinia sappan L. J Ethnopharmacol. 2023;304:116020. (IF: 5.195)

    2. Li, T.T.*; Zheng, R.Y.; Xu, L.J.; Zhou, M.X.; Wang, X.J.; Qianqian Guo, Q.Q.; Hui Ji, H.; Li, L.W*. Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway. Toxicol Appl Pharmacol. 2020;408:115248. (IF: 3.347)

    3. Xu, L.J.; Zheng, R.Y.; Xie, P.; Guo, Q.Q.; Ji, H.; Li, T.T.* Dysregulation of UDP-glucuronosyltransferases in CCl4 induced liver injury rats. Chem Biol Interact. 2020;325:109115. (IF: 3.723)

    4. Li, T.T.; Xu, L.J.; Zheng, R.Y.; Wang, X.J.; Li, L.W.; Ji, H.*, Hu Q.H.* Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor. Phytomedicine. 2020;68:153153. (IF: 4.268)

    5. Li, T.T.; Jiang, S.D.; Ni, B.W.; Cui, Q.J.; Liu, Q.N.; Zhao, H.P.* Discontinued Drugs for the Treatment of Cardiovascular Disease from 2016 to 2018. Int J Mol Sci. 2019; 20: 4513. (IF: 4.183)

    6. Wang, W.S.; Ji, H.*; Li, T.T.*; Jia, Y.W.; Xie, H.T. Pharmacokinetic comparisons of S-oxiracetam   and R-oxiracetam in beagle dogs. Acta Pharm. 2016, 66: 279-287. (IF: 1.212)

    7. Li, T.T.; Hua, K.; Sheng, X.; Liu, L.; Tan, J.N.; Wang, L.N.; Wei, B.; Ji, H.*; Zhang, Y.H.* An HPLC method for the quantitation of 3-pentylbenzo[c]thiophen-1(3H)-one in dog plasma and its application to a pharmacokinetic study. Biomed Chromatogr. 2014, 28: 1592-1596. (IF: 1.723)

    8. Liu, L.#; Li, T.T.#; Tan, J.N.; Fu, J.J.; Guo, Q.Q.; Ji, H.*; Zhang, Y.H.* NG as a novel nitric oxide donor induces apoptosis by increasing reactive oxygen species and inhibiting mitochondrial function in MGC803 cells. Int Immunopharmacol. 2014, 23: 27-36. (Co-first author) (IF: 2.711)

    9. Wang, X.L. #; Wang, L.N. #; Li, T.T.#; Huang, Z.J.; Lai, Y.S.; Ji, H.*; Wan, X.L.; Xu, J.Y. *; Tian, J.D.; Zhang, Y.H.* Novel hybrids of optically active ring-opened 3-n-butylphthalide derivative and isosorbide as potential anti-ischemic stroke agents. J Med Chem. 2013, 56 (7) : 3078-3089. (Co-first author) (IF: 5.4)